Aronson JK. Coronaviruses - a general introduction (2020) Available at: https://www.cebm.net/covid-19/coronaviruses-a-general-introduction/
Google Scholar
Banik GR, Alqahtani AS, Booy R, Rashid H (2016) Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia. Virol Sin 31:81–84
PubMed
PubMed Central
Google Scholar
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff MK (2020) The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. https://doi.org/10.1016/j.antiviral.2020.104787
Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, Zhou J, Shi G, Fang N, Fan J, Cai J, Fan J, Lan F (2020) Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv, https://doi.org/10.1101/2020.02.03.931766 (preprint).
Chen J (2020) Pathogenicity and transmissibility of 2019-ncov-a quick overview and comparison with other emerging viruses. Microbes Infect 22:69–71
CAS
PubMed
PubMed Central
Google Scholar
Chen X, Howard OM, Yang X, Wang L, Oppenheim JJ, Krakauer T (2002) Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function. Life Sci 70:2897–2913
CAS
PubMed
Google Scholar
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395:507–513
CAS
PubMed
PubMed Central
Google Scholar
Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G (2005) Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 24:44–46
CAS
PubMed
Google Scholar
Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM (2020) Molecular diagnosis of a novel coronavirus (2019-ncov) causing an outbreak of pneumonia. Clin Chem 66:549–555
PubMed
PubMed Central
Google Scholar
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DGJC, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MPG, Drosten C (2020) Detection of 2019 novel coronavirus (2019-ncov) by real-time rt-pcr. Euro Surveillance 25:2000045
PubMed Central
Google Scholar
Deng YF, Aluko RE, Jin Q, Zhang Y, Yuan LJ (2012) Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm Biol 50:401–406
CAS
PubMed
Google Scholar
Dietz W (2020) Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring). https://doi.org/10.1002/oby.22818
ECDC (European Centre for Disease Prevention and Control). Seventh and Eighth update (2020a) Available at: (https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019-covid-19-pandemic) and (https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases).
ECDC (European Centre for Disease Prevention and Control) (2020b) Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA, Available at: https://www.ecdc.europa.eu/en/publications-data/coronavirus-disease-2019-covid-19-and-supply-substances-human-origin-eueea
El-Rafie HM, Hamed MA (2014) Antioxidant and anti-inflammatory activities of silver nanoparticles biosynthesized from aqueous leaves extracts of four Terminalia species. Adv Nat Sci: Nanosci Nanotechnol 5:1–11
Google Scholar
Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS (2007) Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol 81:9812–9824
CAS
PubMed
PubMed Central
Google Scholar
FUJIFILM Toyama Chemical Co., Ltd (2020). Information of Avigan Tablet in relation to COVID-19. Available at: http://fftc.fujifilm.co.jp/en/avigan/index.html
Fung KP, Leung PC, Tsui KW, Wan CC, Wong KB, Waye MY, Au WN, Wong CK, Lam WK, Lau BS (2011) Immunomodulatory activities of the herbal formula Kwan Du Bu Fei Dang in healthy subjects: a randomised, double-blind, placebo-controlled study. Hong Kong Med J 2:41–43
Google Scholar
Furuta Y, Komeno T, Nakamura T (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93:449–463
CAS
PubMed
PubMed Central
Google Scholar
Gao Y, Fang L, Cai R, Zong C, Chen X, Lu J, Qi Y (2014) Shuang-Huang-Lian exerts anti-inflammatory and anti-oxidative activities in lipopolysaccharide stimulated murine alveolar macrophages. Phytomedicine 21:461–469
PubMed
Google Scholar
Gong SJ, Su XJ, Yu HP, Li J, Qin YJ, Xu Q (2008) A study on anti-SARS-CoV 3CL protein of flavonoids from litchi chinensis sonn core. Chinese Pharmacol Bull 24:699–700
Google Scholar
Gralinski LE, Menachery VD (2020) Return of the coronavirus: 2019-nCoV. Viruses 12, Epub 2020/01/30. https://doi.org/10.3390/v12020135
Guastalegname M, Vallone A (2020) Could chloroquine /hydroxychloroquine be harmful in coronavirus disease 2019 (COVID-19) treatment? Clin Infect Dis, pii: ciaa321. doi: 10.1093/cid/ciaa321.
Hamed MA, Mohammed MA, Aboul Naser AF, Matloub AA, Fayed DB, Ali SA, Khalil WKB (2019) Optimization of curcuminoids extraction for evaluation against Parkinson’s disease in rats. Under review, J Biol Active Prod Nat 9:335–351
CAS
Google Scholar
Hamed MA, Aboul Naser AF, Aziz WM, Ibrahim FM, Ali SA, El-Rigal NS, Khalil WKB (2020) Natural sources, dopaminergic and non-dopaminergic agents for therapeutic assessment of Parkinsonism in rat model. Pharm Nut. https://doi.org/10.1016/j.phanu.2019.100171
He Y, Zhou Y, Siddiqui P, Jiang S (2004) Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochem Biophys Res Commun 325:445–452
CAS
PubMed
PubMed Central
Google Scholar
Hegarty PK, Kamat A, Zafirakis H, DiNardo A (2020) BCG vaccination may be protective against Covid-19. Eur J Clin Invest, DOI: 10.13140/RG.2.2.35948.10880. Available at: https://www.researchgate.net/publication/340224580_BCG_vaccination_may_be_protective_against_Covid-19
Hempelmann E (2007) Hemozoin biocrystallization in plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Parasitol Res 100:671–676
PubMed
Google Scholar
Ho T, Wu S, Chen J, Li C, Hsiang C (2007) Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 74:92–101
CAS
PubMed
Google Scholar
Holmes KV (2003) SARS-associated coronavirus. N Engl J Med 348:1948–1951
PubMed
Google Scholar
Hu TY, Frieman M, Joy Wolfram J (2020) Insights from nanomedicine into chloroquine efficacy against COVID-19. Nature Nanotechnol. https://doi.org/10.1038/s41565-020-0674-9
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506
CAS
PubMed
PubMed Central
Google Scholar
Hung IF, To KK, Lee CK, Chan K, Yan WW, Liu R, Watt CL, Chan WM, Lai KY, Koo CK, Buckley T, Chow FL, Wong KK, Chan HS, Ching CK, Tang BS, Lau CC, Li IW, Liu SH, Chan KH, Lin CK, Yuen KY (2011) Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 52:447–456
PubMed
Google Scholar
Iqbal A, Prince LR, Novodvorsky P, Bernjak A, Thomas MR, Birch L, Lambert D, Kay LJ, Wright FJ, Macdonald IA, Jacques RM, Storey RF, McCrimmon RJ, Francis S, Heller SR, Sabroe I (2019) Effect of hypoglycemia on inflammatory responses and the response to low-dose endotoxemia in humans. J Clin Endocrinol Metab 104:1187–1199
PubMed
Google Scholar
Jo S, Kim H, Kim S, Shin DH, Kim MS (2019) Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem Biol Drug Des 94:2023–2030
CAS
PubMed
PubMed Central
Google Scholar
Jo S, Kim S, Shin DH, Kim MS (2020) Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem 35:145–151
CAS
PubMed
Google Scholar
Kampf G (2018) Antiseptic stewardship: biocide resistance and clinical implications. Springer International Publishing, Switzerland, DOI: https://doi.org/10.1007/978-3-319-98785-9.
Kampf G, Todt D, Pfaender S, Steinmann E (2020) Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 104:246–251
CAS
PubMed
PubMed Central
Google Scholar
Keyaerts E, Li S, Vijgen L, Rysman E, Verbeeck J, Van Ranst M, Maes P (2009) Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother 53:343416–343421
Google Scholar
Khalili JS, Zhu H, Mak A, Yan Y, Zhu Y (2020) Novel coronavirus treatment with ribavirin: groundwork for evaluation concerning COVID-19. J Med Virol. https://doi.org/10.1002/jmv.25798
Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, AK ME, Sealy T, Campbell S, Spiropoulou C, Ströher U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS (2015) Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit. The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States. Clin Infect Dis 61:496–502
PubMed
PubMed Central
Google Scholar
Kreutz R, Abd El-Hady Algharably E, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M (2020) Hypertension, the renin–angiotensin system, and‘ the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovas Res. https://doi.org/10.1093/cvr/cvaa097
Lau KM, Lee KM, Koon CM, Cheung CS, Lau CP, Ho HM, Lee MY, Au SW, Cheng CH, Lau CB, Tsui SK, Wan DC, Waye MM, Wong KB, Wong CK, Lam CW, Leung PC, Fung KP (2008) Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol 118:79–85
PubMed
PubMed Central
Google Scholar
Leggio M, Lombardi M, Caldarone E, Severi P, D’Emidio S, Armeni M, Bravi V, Bendini MG, Mazza A (2017) The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertension Res 40:947–963
Google Scholar
Li WH, Moore MJ, Vasilieva NY, Sui JH, Wong SK, Berne AM, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454
ADS
CAS
PubMed
PubMed Central
Google Scholar
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, KSM L, EHY L, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, TTY L, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Eng J Med 382:1199–1207
CAS
Google Scholar
Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, Hsieh CC, Chao PD (2005) Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 68:36–42
CAS
PubMed
PubMed Central
Google Scholar
Liu W, Li H (2020) COVID -19: Attacks the 1-Beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. 2020. Available at: https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173
Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante C, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S (2004) Interaction between the heptad repeat 1 and 2 regions in spike protein of SARS associated coronavirus: implication for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363:938–947
CAS
PubMed
PubMed Central
Google Scholar
Lu H (2020) Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 14:69–71
CAS
PubMed
Google Scholar
Luo W, Su X, Gong S, Qin Y, Liu W, Li J, Yu H, Xu Q (2009) Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci Trends 3:124–126
CAS
PubMed
Google Scholar
Martinez MAJAA (2020) Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother, pii: AAC.00399-20. doi: 10.1128/AAC.00399-20.
Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis 17:e792–e798
PubMed
PubMed Central
Google Scholar
Nguyen TTH, Woo HJ, Kang HK, Nguyen VD, Kim YM, Kim DW, Kim DW, Ahn SA, Xia Y, Kim D (2012) Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett 34:831–838
CAS
PubMed
PubMed Central
Google Scholar
Oyekale AS (2019) Effect of obesity and other risk factors on hypertension among women of reproductive age in Ghana: an instrumental variable probit model. Int. J. Environ. Res. Public Heal 16:4699
Google Scholar
Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI, Gutierrez RA, Gwee SXW, Chua PEY, Yang Q, Ng XY, Yap RK, Tan HY, Teo YY, Tan CC, Cook AR, Yap JC, Hsu LY (2020) Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J Clin Med 9:E623
PubMed
Google Scholar
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S (2020) Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 79:104212
CAS
PubMed
PubMed Central
Google Scholar
Peiris JS, Guan Y, Yuen KY (2004) Severe acute respiratory syndrome. Nat Med 10:S88–S97
CAS
PubMed
PubMed Central
Google Scholar
Qingxian C, Fengjuan C, Fang L, Xiaohui L, Tao W, Qikai W, Qing H, Zhaoqin W, Yingxia L, Jun C, Lei L, Lin X (2020) Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Lancet Infect Dis, https://ssrn.com/abstract=3556658
Qu D, Zheng B, Yao X, Guan Y, Yuan ZH, Zhong NS, Lu LW, Xie JP, Wen YM (2005) Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice. Vaccine 23:924–931
CAS
PubMed
Google Scholar
Raoult D, Alimuddin Zumla A, Locatelli F, Ippolito G, Kroemer G (2020) Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress, DOI:10.15698/cst2020.04.216
Rossignol JF (2014) Nitazoxanide: a first-in-class broad-spectrumantiviral agent. Antiviral Res 110:94–103
CAS
PubMed
PubMed Central
Google Scholar
Rossignol JF (2016) Nitazoxanide, a new drug candidate forthe treatment of Middle East respiratorysyndrome coronavirus. J Inf Public Heal 9:227–230
Google Scholar
Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R (2003) Effects of chloroquine on viral infections: an old drug against today’s diseases? Lancet Infect Dis 3:722–727
CAS
PubMed
PubMed Central
Google Scholar
Takahashi S, Yoshiya T, Yoshizawa-Kumagaye K, Sugiyama T (2015) Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomed Res 36:219–224
CAS
PubMed
Google Scholar
Tang X, Wu C, Li X, Song Y, Yao X, Wu X, Duan Y, Zhang H, Wang Y, Qian Z, Cui J, Lu J (2020a) On the origin and continuing evolution of SARS-CoV-2. Nat Sci Rev https://doi.org/10.1093/nsr/nwaa036
Tang X, Zhang S, Peng Q (2020b) Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection. Aci Advan. https://doi.org/10.1126/sciadv.aaz0374
Tripet B, Howard MW, Jobling M, Holmes RK, Holmes KV, Hodges RS (2004) Structural characterization of the SARS-coronavirus spike S fusion protein core. J Biol Chem 279:20836–20849
CAS
PubMed
Google Scholar
Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. https://doi.org/10.1128/JVI.00127-20
Wang D, Lu J (2004) Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV. Physiol Genomics 18:245–248
CAS
PubMed
PubMed Central
Google Scholar
Wang W, Ma X, Han J, Zhou M, Ren H, Pan Q, Zheng C, Zheng Q (2016) Neuroprotective effect of scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor. PLoS One 11:e0146197
PubMed
PubMed Central
Google Scholar
Wang A, Zhao W, Xu Z, Gu J (2020a) Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. https://doi.org/10.1016/j.diabres.2020.108118
Wang W, Lu J, Gu W, Zhang Y, Liu J, Ning G (2020b) Care for diabetes with COVID-19: advice from China. H. Diabetes. https://doi.org/10.1111/1753-0407.13036
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020c) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269–271
CAS
PubMed
PubMed Central
Google Scholar
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang L, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu Y, Wong P, Braun MR, Flint M, LK MM, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S (2016) Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531:381–385
ADS
CAS
PubMed
PubMed Central
Google Scholar
WHO (2020) Coronavirus disease 2019 (COVID-19), Situation Report – 78. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200407-sitrep-78-covid-19.pdf?sfvrsn=bc43e1b_2
Wong SK, Li W, Moore MJ, Choe H, Farzan M (2003) A 193-amino-acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 279:3197–3201
PubMed
Google Scholar
Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA, DOI: https://doi.org/10.1001/jama.2020.2648. PubMed PMID: 32091533.
Wulan WN, Heydet D, Walker EJ, Gahan ME, Ghildyal R (2015) Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses. Front Microbiol 6:553
PubMed
PubMed Central
Google Scholar
Wurm T, Chen H, Hodgson T, Britton P, Brooks G, Hiscox JA (2001) Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division. J Virol 75:9345–9356
CAS
PubMed
PubMed Central
Google Scholar
Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY (2006) Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 23:623–638
CAS
PubMed
Google Scholar
Yang Y, Islam S, Wang J, Li Y, Xin Chen X (2020) Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Internat J Biol Sci 16:1708–1717
Google Scholar
Yi L, Li Z, Yuan K, Qu X, Chen J, Wang G, Zhang H, Luo H, Zhu L, Jiang P, Chen L, Shen Y, Luo M, Zuo G, Hu J, Duan D, Nie Y, Shi X, Wang W, Han Y, Li T, Liu Y, Ding M, Deng H, Xu X (2004) Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 78:11334–11339
CAS
PubMed
PubMed Central
Google Scholar
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820
CAS
PubMed
Google Scholar
Zhang C, Shi L, Wang SF (2020) Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol, https://doi.org/10.1016/S2468-1253(20)30057-1.
Zhao J, Liao X, Wang H, Wei L, Xing M, Liu L, Zhang Z (2020) Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa408
Zhong NS, Zheng BJ, Li YM, Poon LLM, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, Liu XQ, Xu J, Li DX, Yuen KY, Peiris GY (2003) Epidemiology and cause of severe acute respiratory syndrome (SARS) in guangdong, people’s republic of China, in February, 2003. Lancet 362:1353–1358
CAS
PubMed
PubMed Central
Google Scholar
Zhou J, Tan J (2020) Diabetes patients with COVID-19 need better care. Metabolism. https://doi.org/10.1016/j.metabol.2020.154216
Zhou B, Zhong N, Guan Y (2007) Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357:1450–1451
CAS
PubMed
Google Scholar
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Phil D, Tan W (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733
CAS
PubMed
PubMed Central
Google Scholar
Zou C (2020) Coronavirus: Chinese researchers claim TCM herbal remedy could ‘inhibit’ 2019-nCoV. Available at: https://www.bioworld.com/articles/432838-coronavirus-chinese-researchers-claim-tcm-herbal-remedy-could-inhibit-2019-ncov.